The search for systemic fungal infections continues to be important because of the growing population of immunocompromised patients. 1 There is, therefore, a need for more effective antifungal agents. Two new antifungal agents, ZD0870 2 and Sch45450, 3 show potent broad-spectrum antifungal activities compared to other clinically used antifungal agents. Because these compounds contain chiral centers comprised of a difluorobenzene and a triazole group, an optically ...